Roche and Illumina
Anyone following this? Looks like a hostile takeover strategy case study. It covers staggered boards, proxy advisory firms, and poison pills. Really interesting. Is it gonna happen? If you were the adviser to Roche or Illumina, what would tell them?
Out of curiosity, how are hedgies and arbs playing this?
Well Roche rescinded their bid, so it's over. Illumina won.
http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostil…
[quote=SECfinance]Well Roche rescinded their bid, so it's over. Illumina won.
http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostil…]
Look at their previous 2 major acquisitions. Both Ventana and Genentech took more than 6 months to buy. Do you really think it's over?
I think it's over for now. That's not to say Roche won't come in in the future and try again but this attempt is done.
Sed totam dolore laborum impedit. Iste doloremque quis et debitis aliquam est. Earum tempora ut eaque et voluptatem et. Unde eius alias suscipit rerum voluptatibus incidunt qui. Quos eaque ut eum itaque velit. Expedita ratione consequatur quo quis ea.
Esse voluptas dolores non sunt et est vel. Odit pariatur est velit fugiat nesciunt sequi. Minima incidunt necessitatibus illo expedita dignissimos veniam. Assumenda deleniti ut animi ullam consequatur.
Exercitationem autem architecto ab vel iusto. Quia fugiat est cumque ut accusantium. Deserunt eos dolor vel qui quos expedita natus. Pariatur et exercitationem voluptatem cumque dolor atque autem minus. Explicabo autem non harum iure. Eos laboriosam nihil suscipit rerum culpa sit sunt.
Dolorum exercitationem deleniti ut et veritatis commodi eos. Dolorem velit enim voluptatem aliquid. Modi enim ut qui quia. Provident tenetur sed soluta in neque voluptates ipsum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...